Supplementary figure 3. Concentration-effect curve for dupilumab level at 12 weeks and ΔEASI at 48 weeks.

Concentration-effect curve showing the dupilumab serum level in μg/mL at 12 weeks on the x-axis and correlating ΔEASI at 48 weeks (versus baseline) on the y-axis. All patients were sorted from low to high drug concentration, with each dot representing the mean concentration with SDs and correlating ΔEASI for 10 patients (last group 12 patients).